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respectively (controls: 2541±293pmol/g) (p<0.05). Although sub-
stance P levels in the the ACLT+pMMx (160±39 pmol/g) and the
MIA model (226±67pmol/g) were elevated when compared to the
control group (111±49 pmol/g), this difference was not statistically
signiﬁcant. However, dynorphin concentrations were signiﬁcantly
decreased with concentrations of 370±70 and 418±107 in the
ACLT+pMMx and MIA models respectively (controls: 779±111
pmol/g) (p<0.05). Histological evaluation revealed severe carti-
lage loss in the MIA model and comparatively minor changes
in the ACLT+pMMx model, conﬁrming articular lesions in both
models.
Conclusions: Clearer behavioural nociceptive responses related
to gait parameters of the osteoarthritic limb were seen with the MIA
model suggesting that it may be a better model for the evaluation
of therapeutic strategies for joint pain palliation when compared to
the ACLT+pMMx model, with respect to the length of the study.
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Purpose: Protein Kinase C zeta (PKCζ) is an atypical PKC that
is up-regulated in human osteoarthritis (OA) and has a role in
aggrecanase induction and proteoglycan release. This study was
designed to compare the severity of osteoarthritis (OA) in wild-
type (WT) and PKCζ knock out (KO) mice following challenge in a
surgical-instability model.
Methods: All animal studies were performed with IACUC ap-
provals. The PKCζ KO was generated in-house on a 129SvEv
background with deletion of exon 7 resulting in a frameshift stop
and elimination of both PKCζ and PKMζ expression. PKCζ KO and
sibling WT male mice (22 per group) underwent surgical desta-
bilization of the medial meniscus (DMM) when 10 weeks of age,
and were group housed until sacriﬁced 8 weeks later. Following
euthanasia, right knees were collected for histopathologic evalua-
tion of cartilage degeneration. Safranin-O stained parafﬁn sections
were examined at 80μm intervals through the joint to generate
both summed and maximal scores from all 4 quadrants of the
femoro-tibial joint.
Results: The PKCζ KO mice were grossly normal with no fertility
issues. Severe cartilage degeneration was observed in the sibling
WT at 8-weeks following DMM. In contrast, the PKCζ KO had only
mild to moderate cartilage degeneration. The cartilage degener-
ation scores revealed very signiﬁcant decreases in summed and
maximal scores in the PKCζ KO, when compared to sibling WT.
Conclusions: Previous studies have found that PKCζ expression
is transcriptionally up-regulated in human OA cartilage compared
to normal cartilage, is rapidly phosphorylated following IL-1 stimu-
lation, and PKCζ inhibitors can block aggrecanase expression and
proteoglycan release from cartilage explants. This study demon-
strated that deletion of the catalytic domain of PKCζ (present in
both PKCζ and PKMζ) provides signiﬁcant protection in the DMM
model in the mouse. Previous DMM studies (not published) have
shown a lack of protection with a different PKCζ KO, which main-
tained PKMζ expression. These ﬁndings indicate the importance
of the catalytic domain of PKCζ and the potential of inhibitors
selectively directed to this region to provide disease-modiﬁcation
for the treatment of OA.
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Purpose: Animal models are frequently used in medical research.
The use of the Pond-Nuki model is well established in the ﬁeld of
Osteoarthritis (OA). In the past years, the use of 3D kinematics
has gained in popularity because it provides objective means of
assessing the function of joints/limbs. To this date, most in vitro
studies analyzing kinematics of the canine stiﬂe were made in 2D
under low static loads. To the authors’ knowledge, this model is the
ﬁrst quasi-dynamic weight bearing in vitro model of 3D kinematics
of the canine cranial cruciate ligament deﬁcient stiﬂe.
Goal: Our goal was to use a validated experimental device sim-
ulating a quasi-dynamic model of the stance phase at trot of the
canine hind limb under near physiologic conditions in the cranial
cruciate ligament deﬁcient stiﬂe (CCLDS).
Hypotheses: 1) Kinematics generated by the device is represen-
tative of reported in vivo 3D kinematics in dogs with CCLDS;
2) Peak vertical forces generated by the loaded limbs in the device
are comparable to those recorded in the literature for a trotting
dog during the stance phase.
Methods: Six normal paired hind limbs were harvested from 3
adult large breed dogs euthanatized for reasons unrelated to this
study. The dogs were similar in age, size and body weight (range,
29.5-31 kg). The limbs were prepared and mounted on a previ-
ously validated experimental device. Each limb was submitted to
vertical loading (9 kg). The gait was simulated with a computer-
ized sequence using a linear actuator and a rotational motor. The
stance phase of the gait at trot was simulated three times on each
hind limb. Then, with the limbs still mounted in the device, the cra-
nial cruciate ligament (CCL) was completely transected through a
small medial arthrotomy which was closed using a simple contin-
uous pattern. Kinematics of the tibia and femur was measured in
the 2 situations (intact and CCLDS) with an optoelectronic system.
Vertical ground reaction forces were measured with a 2.5 kN ax-
ial/torsion force transducer. Amplitude of motion and peak ground
reaction forces as well as the general shape of kinematics curves
were also compared with in vivo curves described in the literature.
Results: The comparison of the six average curves of motion
collected on the tested stiﬂes to those from in vivo trials re-
veals similar patterns. Data recorded during in vitro simulations
in CCLDS highlighted the following changes between intact and
CCLDS: an increase in ﬂexion (4°), abduction (2°), internal rota-
tion (3°), cranial translation (4mm), medial translation (1,5mm) and
proximal displacement (3mm) of the tibia were recorded. These
changes are comparable to those reported in vivo. However, the
amplitude of changes is slightly greater on in vivo curves. Peak
vertical forces measured in the device (138±2N) were also similar
to in vivo trials reported in the literature.
Conclusions: Results show that the device generates reliable
motion on a loaded limb which is representative of the in vivo
3D kinematics in CCLDS reported in the literature. This model
could be used to evaluate the impact of OA on kinematics in the
Pond-Nuki model. Furthermore, this model could be used ex vivo
to evaluate the effect of different therapeutic modalities of OA.
Finally and of utmost importance, this model could be adapted
and used with the human knee.
